Clinical Trial Update: Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update covers NB003 for advanced Gastrointestinal Stromal Tumor (GIST) and notes that Phase 2/Phase 3 studies are not yet recruiting. There …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• NB003

Snippet

Sponsor: Ningbo Newbay Technology Development Co., Ltd | Conditions: GIST - Gastrointestinal Stromal Tumor, Advanced | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING